The Stereotactic Radiosurgery Gamma Knife Market is poised for significant growth during the forecast period 2025 to 2035, driven by the rising prevalence of neurological disorders and increasing demand for minimally invasive treatment options. Gamma Knife technology is widely adopted for the precise treatment of brain tumors, functional neurosurgery procedures, arteriovenous malformations (AVMs), and trigeminal neuralgia. Its ability to deliver high-dose radiation with sub-millimeter accuracy while minimizing damage to surrounding healthy tissues continues to enhance clinical outcomes and patient recovery rates.

By technology, the market is segmented into Linear Accelerator (LINAC), Cobalt-60 systems, and Proton Therapy. Cobalt-60-based Gamma Knife systems remain the gold standard for intracranial treatments, while advancements in LINAC and proton therapy technologies are expanding treatment capabilities and improving precision.

Based on end users, hospitals dominate the market due to advanced infrastructure and skilled professionals, followed by ambulatory surgical centers and research institutions. In terms of treatment type, both stereotactic radiotherapy and fractionated radiosurgery are gaining traction due to their flexibility in managing complex and large lesions.

Regionally, North America leads the market owing to advanced healthcare infrastructure, followed by Europe. Meanwhile, Asia Pacific is expected to witness the fastest growth due to improving healthcare investments and rising awareness.

Avail Latest Insights on Healthcare Reports:

GCC Medical Drones Market

Germany Medical Drones Market

India Medical Drones Market

Italy Medical Drones Market

Japan Medical Drones Market

Medical Drones Market

South America Medical Drones Market

South Korea Medical Drones Market

Spain Medical Drones Market